期刊文献+

卡维地洛对高血压病并发2型糖尿病患者血管内皮功能及胰岛素抵抗的影响 被引量:1

Effects of carvedilol on vascular endothelial function and insulin resistance in hypertensive patients with diabetes mellitus
原文传递
导出
摘要 目的:探讨卡维地洛对高血压合并糖尿病患者血管内皮功能及胰岛素抵抗的影响。方法:经2周导入期后熏将41例高血压合并2型糖尿病患者熏随机分为卡维地洛组(21例)和美托洛尔组(20例)。治疗前及治疗6月后熏采静脉血测定空腹胰岛素、空腹血糖熏计算胰岛素敏感性指数;采用高分辨率超声检测反应性充血和硝酸甘油介导的肱动脉舒张功能。结果:卡维地洛治疗6月后,患者收缩压和舒张压均有效下降熏空腹胰岛素降低,胰岛素敏感指数显著升高熏反应性充血和硝酸甘油介导的血管舒张功能均明显改善。美托洛尔治疗后,空腹血糖和空腹胰岛素均轻度升高,胰岛素敏感指数降低,但差异均不具有统计学意义;反应性充血和硝酸甘油介导的血管舒张功能均无明显变化。结论:卡维地洛可有效降低高血压合并2型糖尿病患者的血压,改善胰岛素抵抗及肱动脉内皮依赖性及非内皮依赖性的血管舒张功能。 Objective: To investigate the effects of carvedilol on vascular endothelial function and insulin resistance in hypertensive patients with type 2 diabetes mellitus. Methods: Following discontinuation of any cardiovascular drugs for 2 weeks, 41 patients with arterial hypertension and diabetes mellitus were divided randomly into carvedilol group(21cases) and metoprolol group(20 cases). Before treatment and after 6 months of treatment, fasting glucose and insulin were measured. Insulin sensitivity index was calculated. Reactive congestion and nitroglycerin-induced dilation of the brachial artery were assayed with high-resolution ultrasound. Results:After 6 months of treatment, carvedilol significantly reduced blood pressure. Fasting insulin was reduced and insulin sensitivity index was increased significantly. Reactive congestion and nitroglycerin-induced vasodilatation were improved. And after 6 months of treatment with metoprolol, fasting blood sugar and insulin was increased and insulin sensitivity index was reduced slightly. Reactive congestion and nitroglycerin-induced vasodilatation were not improved. Conclusion: Carvedilol effectively reduced blood pressure and improved insulin resistance, endothelial-dependent vasodilatation and endothelial-independent vasodilatation in hypertensive patients with type 2 diabetes mellitus.
出处 《药物不良反应杂志》 2004年第4期226-228,共3页 Adverse Drug Reactions Journal
关键词 卡维地洛 内皮功能 高血压 糖尿病 胰岛素抵抗 carvedilol endothelial function hypertension diabetes mellitus insulin resistance
  • 相关文献

参考文献7

  • 1Preik M, Kelm M, Rosen P, et al. Additive effect of coexistent type 2 diabetes and arterial hypertension on endothelial dysfunction in resistance arteries of human forearm vasculature[J]. Angiology, 2000; 51(7):545.
  • 2Ross R. The pathogenesis of atherosclerosis-an update[J].N Engl Med, 1998; 341 (8) : 448.
  • 3Ma L, Zhao S, Li J, et al. Interaction of hypertension and diabetes on impairment of endothelial function [J]. Chin Med J, 2001; 114(6):563.
  • 4Celermajer DS, Sorenson KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis [J]. Lancet, 1992; 340(8828) :1111.
  • 5Adams MR, Robinson J, McCredie R, et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis [J]. J Am Coll Cardiol, 1998, 32(1):123.
  • 6Cleland S J, Petrie JR, Connel MS. Insulin action is associated with endothelial function in hypertension and type 2 diabetes[J]. Hypertension, 2000, 35[part]: 507.
  • 7余丹菁,高鑫,赵耐青,孙璇,江孙芳,蒋小红,潘柏申.肥胖患者血清C-反应蛋白水平变化与代谢综合征的关系[J].复旦学报(医学版),2002,29(1):45-49. 被引量:21

二级参考文献16

  • 1Frohlich M, Beiner H, Imbof A, et al. Association between c-reactive protein and features of the metabolic syndrome. Diabetes Care, 2000,23:1835
  • 2Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with metablic syndrome. Diabetes Care, 2001,24:683
  • 3Mendall MA, Patel P, Ballam L, et al. C-reactive protein and its relation to cardiovascular risk factors: a population based croess section study.BMJ, 1996 , 312 :1061
  • 4Grau AJ ,Buggle F,Becher H,et al, The association of leucocyte count,fibroinogen and C-reactive protein with vascular risk factors and rschemic vascular diseases. Thromb Res,1996,82:245
  • 5Juhan Vague I, Thompson SG,Jespersen J. Involvement of the hemostatic system in the insulin resistance syrdrome: a study of 1 500 patients with angina pectoris: the ECTA Angina Pectoris Study Group. Arterioscler Thromb, 1993,13:1865
  • 6Ford ES. Body mass irdex, diabetes, and C-rractive protein among U. S.adults[see comments]. Diabetes Care, 1999,22(12) :1971
  • 7Visser M,Bouter LM,Geraldine MM, et al. Elevated C-reaetrye protein levels in overweight and obese adults. JAMA,1999, 282: 2131
  • 8Cook DG,Mendaii MA,Whincup PH, et al. C reactive protem concen tration in chlldren: relationship to adiposity and other cardiovasular risk factors. Atherosclerosis ,2000,149( 1 ): 139
  • 9Hak AE,Stehouwer CD,Bots ML,et al. Associations of C-reactive pro tein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle aged women. Arterioseler Thromb Va sc Biol, 1999,19(8): 1986
  • 10Pickup JC,Mattock MB,Chusney GD, et al. NIDDM as a disease of the innate immune system: association of acute-phase reactants and inter leulin-6 with metabolic syndrome X. Diabeetologia. 1997,40( 11 ): 1286

共引文献20

同被引文献44

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部